Sundar G. Raman, CEO of Fabric Home & Habitat Care at Procter & Gamble Co, filed a Form 4 on August 24, 2026, reporting the sale of 3,435 shares of common stock on August 21, 2026, to cover taxes on a stock award.
Hesham Abd El Hak, CEO of Baby and Feminine Care at Procter & Gamble Co (NYSE:PG), filed a Form 4 on August 24, 2026, disclosing the sale of 1,936 shares of common stock on August 20, 2026, to cover taxes on a stock award.
Moses Victor Javier Aguilar, Chief Research, Development & Innovation Officer at Procter & Gamble Co, filed a Form 4 on August 24, 2026, disclosing the sale of 3,053 shares of common stock on August 19, 2026.
Director Derrick D. Dockery filed a Form 4 with the SEC on August 24, 2026, disclosing the sale of 12,000 shares of Telos Corporation common stock on August 21, 2026.
Jennifer Yoss, Vice President of Accounting at CorVel Corp, filed a Form 4 on August 24, 2026, disclosing a same-day exercise and sale of common stock options that occurred on August 20, 2026.
Marc N. Casper, Chairman and CEO of Thermo Fisher Scientific Inc. (NYSE:TMO), filed a Form 4 on August 24, 2026, disclosing the exercise of stock options and subsequent sales of common stock on August 20 and August 21, 2026.
Hans Helmerich, a director at Helmerich & Payne, Inc. (NYSE:HP), filed a Form 4 on August 24, 2026, disclosing the sale of 94,470 shares of common stock on August 20, 2026, across three separately held ownership structures.
James Meyer, Senior Vice President and CFO of Thermo Fisher Scientific Inc. (NYSE:TMO), filed a Form 4 on August 24, 2026, disclosing a tax-related share disposition and updated beneficial ownership figures as of August 22, 2026.
Director Denise H. Knouse-Snyder filed a Form 4 with the SEC on August 24, 2026, disclosing the sale of 3,070 shares of WesBanco Inc common stock on that same date.
Samuel J. Anderson, a director at Vicor Corporation, filed a Form 4 on August 24, 2026, reporting five option exercise transactions in Vicor common stock executed on August 20, 2026, on NASDAQ:VICR.